A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels.

Abstract

BACKGROUND Carbohydrate-deficient transferrin (CDT) is an alcohol biomarker recently approved by the U.S. Food and Drug Administration. This test is increasingly being used to detect and monitor alcohol use in a variety of health care, legal, and industrial settings. The goal of this study is to review the genetic, biological, pharmacological, and clinical… (More)

Topics

Cite this paper

@article{Fleming2004ARO, title={A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels.}, author={Michael Francis Fleming and Raymond F. Anton and Claudia Spies}, journal={Alcoholism, clinical and experimental research}, year={2004}, volume={28 9}, pages={1347-55} }